Using robots does not change any financial incentives. This is true for operations as well as diagnosis.
That said, financial considerations will probably still be a big part of the treatment routine.
Devices that overreport are likely to be more popular and more common than devices that underreport. That is in part due to the financial incentives associated with diagnosing.
I think you're on to something. I bet Henry Schein execs/shareholders haven't felt this much energy since patients first saw their dental issues on 36 inch TVs.